微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2026-09-30 | 5.62% | -59.25% | -22.91% | 52/159 | 4.1% | 迪哲医药 | 115.44% | 行业排名> |
| 2026-06-30 | 7.29% | -32.44% | 92.35% | 18/159 | 1.36% | 泽璟制药 | 44.02% | 行业排名> |
| 2026-03-31 | 3.79% | -37.56% | -78.07% | 27/159 | 0.06% | 泽璟制药 | 45.29% | 行业排名> |
| 2025-12-31 | 17.28% | 3.35% | 25.31% | 6/159 | -4.32% | 兴齐眼药 | 38.62% | 行业排名> |
| 2025-09-30 | 13.79% | 11.57% | 27.8% | 10/159 | 1.69% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 10.79% | 3.95% | 77.76% | 6/159 | 0.34% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 6.07% | 10.36% | -63.7% | 6/159 | -0.34% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 16.72% | -18.91% | 35.28% | 10/159 | -9.4% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 12.36% | -26.73% | 19.08% | 16/159 | 4.26% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 10.38% | -6.91% | 88.73% | 6/159 | 2.68% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 5.5% | -24.76% | -73.33% | 6/159 | 2.33% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | 20.62% | -7.12% | 22.23% | 2/159 | -0.94% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 16.87% | -13.49% | 51.3% | 3/159 | 2.36% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 11.15% | -12.14% | 52.53% | 2/159 | 1.49% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | 7.31% | 9.1% | -67.07% | 2/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | 22.2% | 30.97% | 13.85% | 5/159 | 0.84% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 19.5% | 27.95% | 53.66% | 3/159 | 2.87% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | 12.69% | 18.49% | 89.4% | 6/159 | 2.21% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | 6.7% | 23.39% | -60.47% | 2/159 | 1.59% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | 16.95% | 16.98% | 11.22% | 14/159 | 0.87% | ST人福 | 6.82% | 行业排名> |
| 2021-09-30 | 15.24% | 23.6% | 42.3% | 10/159 | 4.45% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 10.71% | 50.63% | 97.24% | 13/159 | 2.99% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 5.43% | 92.55% | -62.53% | 7/159 | 2.48% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 14.49% | 25.67% | 17.52% | 32/159 | 3.82% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 12.33% | 33.73% | 73.42% | 26/159 | 3.15% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 7.11% | 33.4% | 152.13% | 35/159 | 4.28% | 中哲精化 | 45.32% | 行业排名> |
| 2020-03-31 | 2.82% | 89.26% | -75.54% | 36/159 | 2.23% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 11.53% | 18.87% | 25.05% | 48/159 | 2.62% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 9.22% | 2.22% | 72.98% | 39/159 | 7.58% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 5.33% | -32.53% | 257.72% | 43/159 | 5.02% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | 1.49% | -68.89% | -84.64% | 71/159 | 2.44% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 9.7% | -43.64% | 7.54% | 51/159 | 7.16% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 9.02% | -42.29% | 14.18% | 29/159 | 7.2% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 7.9% | -26.85% | 64.93% | 16/159 | 4.62% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 4.79% | -26.53% | -72.17% | 12/159 | 2.57% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 17.21% | 5.07% | 10.11% | 18/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 15.63% | 15.44% | 44.72% | 11/159 | 8.3% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 10.8% | 20.54% | 65.64% | 12/159 | 5.55% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 6.52% | 57.49% | -60.2% | 3/159 | 2.11% | 中哲精化 | 54.24% | 行业排名> |
| 2016-12-31 | 16.38% | 19.3% | 20.97% | 32/159 | 6.11% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 13.54% | 63.33% | 51.12% | 14/159 | 5.7% | ST南新 | 81.7% | 行业排名> |
| 2016-06-30 | 8.96% | 42.22% | 116.43% | 20/159 | 3.56% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 4.14% | -3.94% | -69.85% | 17/159 | 2.69% | 贝达药业 | 16.78% | 行业排名> |